Navigation Links
Jon M. Huntsman Receives American Cancer Society Medal of Honor
Date:11/21/2008

THE WOODLANDS, Texas, Nov. 21 /PRNewswire-FirstCall/ -- Huntsman Corporation (NYSE: HUN) today announced that its Founder and Chairman, Jon M. Huntsman, is one of four Americans chosen by the American Cancer Society to receive this year's Medal of Honor, its highest honor. Given annually, the award is reserved for those who have made outstanding contributions to the fight against cancer.

Noting that Mr. Huntsman and his wife Karen Huntsman have "raised or personally contributed over $600 million to the fight against cancer," the American Cancer Society awarded Mr. Huntsman its Medal of Honor for the category of Cancer Philanthropy.

Huntsman Corporation's President and CEO Peter Huntsman observed, "I and the many thousands of other associates that work for Huntsman Corporation around the globe are immensely proud that our Chairman has chosen to return to society so much of his personal gain from the success of our company."

About Huntsman:

Huntsman is a global manufacturer and marketer of differentiated chemicals. Its operating companies manufacture products for a variety of global industries, including chemicals, plastics, automotive, aviation, textiles, footwear, paints and coatings, construction, technology, agriculture, health care, detergent, personal care, furniture, appliances and packaging. Originally known for pioneering innovations in packaging and, later, for rapid and integrated growth in petrochemicals, Huntsman today has 13,000 employees and operates from multiple locations worldwide. The Company had 2007 revenues of approximately $10 billion. For more information about Huntsman, please visit the company's website at http://www.huntsman.com.

Forward-Looking Statements:

Statements in this release that are not historical are forward-looking statements. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, financial, economic, competitive, environmental, political, legal, regulatory and technological factors. In addition, the completion of any transactions described in this release is subject to a number of uncertainties and closing will be subject to approvals and other customary conditions. Accordingly, there can be no assurance that such transactions will be completed or that the company's expectations will be realized. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.


'/>"/>
SOURCE Huntsman Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
2. Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008
3. Keryx Biopharmaceuticals Receives Nasdaq Notification
4. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card
5. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
6. Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature
7. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
8. Capital BlueCross Receives Prestigious Corporation of the Year Award
9. Bmc nurse manager receives Abstract Award
10. Cancer researcher receives $3.8 million award from US Department of Defense
11. Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Charlottesville, Virginia (PRWEB) , ... January 18, 2017 , ... ... New studies are released almost daily linking gut health to chronic disease, mental health ... the New Year ” as an important resolution to consider. , For one Charlottesville ...
(Date:1/18/2017)... ... 2017 , ... The VA Maryland Health Care System and ... project focused on multiple sclerosis (MS). Led by Christopher M. Jewell, PhD, an ... disease without compromising normal immune function that often occurs during autoimmune diseases. Ultimately ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... most-read publication among specialty pharmacists and pharmacy professionals, has teamed up with ... Partnership (SAP) program, announced Brian Haug, president of Pharmacy Healthcare Communications, LLC, ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans to run the ... charity that provides free surgery to poor children suffering from cleft lip and cleft ... have run to support the efforts of the American Heart Association and the Leukemia ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, a ... business owners in central Maryland and the DC region, is inaugurating a charity event ... people nationally every year, making it the #1 killer in America. However, heart disease ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017 Accuray Incorporated (Nasdaq: ... TomoTherapy® Systems continue to set the bar for excellence ... composite overall user satisfaction rating among radiation treatment delivery ... MD Buyline Market Intelligence Briefing™. The most recent ratings ... ratings among industry peers for 11 of the past ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
(Date:1/19/2017)... -- New Review of Safinamide - ... and Motor Complications in Mid- to Late-stage Parkinson,s ... ... C Warren Olanow , ... 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published recently ...
Breaking Medicine Technology: